Scientists ID potential treatment for deadliest brain cancer
Glioblastoma strikes 200,000 people each year worldwide, and has no cure UVA Comprehensive Cancer Center researchers led by Hui Li have found a small molecule that blocks AVIL, a key […]
Noninvasive Blood Test Launched for Myeloma MRD Monitoring
Quest Diagnostics has launched a new blood-based test—Quest Flow Cytometry MRD for Myeloma—to monitor measurable residual disease (MRD) in multiple myeloma patients across the U.S. The test uses advanced flow cytometry […]
First patient recruited in clinical trial using cancer-targeting virus
The first patient has been treated in a clinical trial that is testing a pioneering virus technology – which originated at Cardiff University – that infects cancer cells, producing an […]
Exploring the survival tactics of childhood cancers
Childhood cancers remain the leading cause of disease-related death in young people partly because many tumours become treatment-resistant and relapse. Unlike adult cancers, paediatric tumours carry very few genetic mutations. […]
Data-driven Cancer Research Conference
Our next event is taking place at the Edinburgh International Conference Centre from 24-26 February 2026. Introduction and learning objectives Building on the success of our sold-out 2024 inaugural event, […]
Scientists develop a drug to stop cancers resisting chemotherapy
Researchers at King’s College London have developed a new “companion drug,” KCL-HO-1i, designed to make chemotherapy more effective by dismantling the immune barriers that protect tumours. Tumours recruit immune cells […]